Cite
APA Citation
Mahalingam, D., Patel, M. R., Sachdev, J. C., Hart, L. L., Halama, N., Ramanathan, R. K., Sarantopoulos, J., Völkel, D., Youssef, A., de Jong, F. A., & Tsimberidou, A. M. (2020). phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours. British journal of clinical pharmacology, 86(9), 1836–1848. http://access.bl.uk/ark:/81055/vdc_100106940558.0x000051